d-alpha tocopherol has been researched along with itraconazole in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| André, J; De Doncker, P; Luyten, C; Walraevens, C | 1 |
| Hong, JY; Kim, CK; Kim, JK; Park, JS; Song, YK | 1 |
| Mididoddi, PK; Repka, MA; Trey, SM; Wicks, DA | 1 |
| Armas, HN; D'Autry, W; Janssens, S; Nagels, S; Van den Mooter, G; Van Schepdael, A | 1 |
| Augustijns, P; Froyen, L; Houthoofd, K; Martens, JA; Mols, R; Van den Mooter, G; Van Eerdenbrugh, B; Van Humbeeck, J; Van Speybroeck, M | 1 |
| Augustijns, P; Froyen, L; Humbeeck, JV; Martens, JA; Van den Mooter, G; Van Eerdenbrugh, B; Vermant, J | 1 |
| De Zordi, N; Macchiavelli, S; Moneghini, M; Princivalle, F; Solinas, D | 1 |
| Amighi, K; Duret, C; Sebti, T; Vanderbist, F; Wauthoz, N | 1 |
| Chen, H; Hu, B; Hu, Y; Li, S; Qiu, L; Wu, X; Zheng, Y | 1 |
| Lang, B; Liu, S; McGinity, JW; Williams, RO | 1 |
| Chantasart, D; Mingkwan, T; Suksiriworapong, J | 1 |
| Chow, AHL; Chow, SF; Wan, KY; Wong, KW | 1 |
| Coutinho, P; de Jesús Valle, MJ; Ribeiro, MP; Sánchez Navarro, A | 1 |
| Alhowyan, AA; Alkholief, M; Alshamsan, A; Altamimi, MA; Badran, M; Binkhathlan, Z; Kalam, MA; Khan, AA | 1 |
| Collas, A; Nandi, S; Padrela, L; Tajber, L | 1 |
1 review(s) available for d-alpha tocopherol and itraconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for d-alpha tocopherol and itraconazole
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Yellow nail syndrome and onychomycosis. Experience with itraconazole pulse therapy combined with vitamin E.
Topics: Adult; Antifungal Agents; Bronchial Diseases; Drug Therapy, Combination; Female; Humans; Itraconazole; Nail Diseases; Onychomycosis; Pigmentation Disorders; Sinusitis; Syndrome; Vitamin E | 1996 |
A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
Topics: alpha-Tocopherol; Animals; Antifungal Agents; Area Under Curve; Biological Availability; Capsules; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Emulsions; Ethylene Glycols; Food-Drug Interactions; Hydrochloric Acid; Intestinal Absorption; Itraconazole; Male; Oils; Particle Size; Poloxamer; Rats; Rats, Sprague-Dawley; Solubility; Surface-Active Agents; Tocopherols | 2006 |
Delivery of itraconazole from extruded HPC films.
Topics: Administration, Topical; alpha-Tocopherol; Antifungal Agents; Antioxidants; Calorimetry, Differential Scanning; Cellulose; Chromatography, High Pressure Liquid; Crystallization; Delayed-Action Preparations; Drug Carriers; Drug Stability; Itraconazole; Kinetics; Molecular Weight; Onychomycosis; Technology, Pharmaceutical; Thermogravimetry; X-Ray Diffraction | 2007 |
Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Dosage Forms; Drug Compounding; Drug Delivery Systems; Drug Evaluation, Preclinical; Excipients; Gas Chromatography-Mass Spectrometry; Itraconazole; Polyethylene Glycols; Povidone; Pyrrolidines; Solubility; Temperature; Vinyl Compounds; Vitamin E; X-Ray Diffraction | 2008 |
Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance.
Topics: Animals; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Stability; Itraconazole; Male; Polyethylene Glycols; Powders; Rats; Rats, Wistar; Silicon Dioxide; Vitamin E; X-Ray Diffraction | 2009 |
Solubility increases associated with crystalline drug nanoparticles: methodologies and significance.
Topics: Acetamides; Acetophenones; Chemistry, Pharmaceutical; Crystallization; Drug Stability; Excipients; Itraconazole; Light; Micelles; Nanoparticles; Naproxen; Nephelometry and Turbidimetry; Particle Size; Phenytoin; Polyethylene Glycols; Scattering, Radiation; Solubility; Suspensions; Vitamin E | 2010 |
Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology.
Topics: Calorimetry, Differential Scanning; Crystallization; Dosage Forms; Drug Compounding; Drug Delivery Systems; Itraconazole; Microwaves; Polyethylene Glycols; Spectroscopy, Fourier Transform Infrared; Surface-Active Agents; Vitamin E; X-Ray Diffraction | 2010 |
Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Topics: Administration, Inhalation; Aerosols; Antifungal Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Compounding; Excipients; Itraconazole; Mannitol; Particle Size; Polyethylene Glycols; Powders; Solubility; Transition Temperature; Vitamin E; X-Ray Diffraction | 2012 |
Antifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.
Topics: Animals; Antifungal Agents; Candida albicans; Cell Survival; HeLa Cells; Humans; Itraconazole; Mice; Nanoparticles; Polyethylene Glycols; Vitamin E | 2015 |
Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
Topics: Animals; Chemistry, Pharmaceutical; Hydrophobic and Hydrophilic Interactions; Itraconazole; Polymers; Rats; Rats, Sprague-Dawley; Solubility; Vitamin E | 2016 |
Enhanced transmucosal delivery of itraconazole by thiolated d-ɑ-tocopheryl poly(ethylene glycol) 1000 succinate micelles for the treatment of Candida albicans.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Humans; Itraconazole; Micelles; Mouth Mucosa; Nanoparticles; Polymers; Vitamin E | 2017 |
Impact of molecular rearrangement of amphiphilic stabilizers on physical stability of itraconazole nanoparticles prepared by flash nanoprecipitation.
Topics: Antifungal Agents; Chemical Precipitation; Drug Compounding; Drug Stability; Itraconazole; Microscopy, Atomic Force; Nanoparticles; Photoelectron Spectroscopy; Polyethylene Glycols; Vitamin E | 2018 |
Lyophilized tablets for focal delivery of fluconazole and itraconazole through vaginal mucosa, rational design and in vitro evaluation.
Topics: Antifungal Agents; Drug Design; Drug Liberation; Female; Fluconazole; Freeze Drying; Humans; Itraconazole; Liposomes; Mucous Membrane; Tablets; Vagina; Vitamin E | 2018 |
Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies.
Topics: Antifungal Agents; Candida albicans; Chemical Precipitation; Desiccation; Drug Liberation; Freeze Drying; Itraconazole; Nanoparticles; Particle Size; Solubility; Vitamin E; X-Ray Diffraction | 2019 |
Development of long-acting injectable suspensions by continuous antisolvent crystallization: An integrated bottom-up process.
Topics: Chemistry, Pharmaceutical; Crystallization; Itraconazole; Particle Size; Solubility; Solvents; Suspensions; Vitamin E | 2023 |